Literature DB >> 9072669

[Risk factors and prevention of thyroid carcinoma].

G Lupoli1, E Cascone, G Vitale, F Arlotta, V Nuzzo, G Lupoli1, B Cassese.   

Abstract

Thyroid carcinoma represents the most frequent endocrine tumor. Recent reports have documented an increase in the incidence of thyroid cancer. Its incidence varies geographically around the world from 0.9/ 100,000 men and 2.4/100,000 women in Great Britain to 8.8/100,000 men and 18.2/ 100,000 women in Hawaii. Radiation exposure has been strongly implicated as an aetiological factor. The greatest risk occurs with acute exposure to X and/or gamma rays, with a linear dose response curve, while the risk is inversely related to age at exposure with a latent period of 5-20 years. Together with irradiation, other factors (iodine, alcohol and calcium diet intake, hyperthyroidism, Hashi-moto's thyroiditis, Gardner syndrome, Cowden syndrome, pharmaceutical agents, hormonal factors, occupational exposure, activation of cellular oncogenes) have been associated with the risk of thyroid cancer. In prevention a policy should include regulations and methods for avoiding radiation exposure of the thyroid and for preventing nutritional deficiency and excess of iodine. Besides, early and continuous suppressive therapy of all patients affected by non-toxic goiter or treated previously with thyroidectomy, and a screening of medullary thyroid carcinoma (MTC) using pentagastrin stimulation test and restriction fragment length polymorphism analysis, in subjects with a familial history of MTC, are of paramount importance to prevent thyroid cancer.

Entities:  

Mesh:

Year:  1996        PMID: 9072669

Source DB:  PubMed          Journal:  Minerva Endocrinol        ISSN: 0391-1977            Impact factor:   2.184


  2 in total

1.  The use and availability of thyroid shields in orthopaedic theatres: a telephone questionnaire of English hospitals.

Authors:  M R Cope; D L Shaw
Journal:  Ann R Coll Surg Engl       Date:  2002-05       Impact factor: 1.891

2.  Thyroid Cancer-Associated Mitochondrial DNA Mutation G3842A Promotes Tumorigenicity via ROS-Mediated ERK1/2 Activation.

Authors:  Sixi Chen; Xinzhu Bao; Hongzhi Chen; Manli Jia; Wen Li; Luyi Zhang; Runxiao Fan; Hezhi Fang; Liqin Jin
Journal:  Oxid Med Cell Longev       Date:  2022-03-15       Impact factor: 7.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.